ArticleHead & neck2022

Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.

Mark C Korpics et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.